Ikarian Capital, LLC Galectin Therapeutics Inc Transaction History
Ikarian Capital, LLC
- $606 Million
- Q4 2024
A detailed history of Ikarian Capital, LLC transactions in Galectin Therapeutics Inc stock. As of the latest transaction made, Ikarian Capital, LLC holds 1,200,000 shares of GALT stock, worth $1.94 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
1,200,000
Previous 500,000
140.0%
Holding current value
$1.94 Million
Previous $1.38 Million
3.85%
% of portfolio
0.24%
Previous 0.24%
Shares
1 transactions
Others Institutions Holding GALT
# of Institutions
112Shares Held
9.93MCall Options Held
3.78MPut Options Held
5.27M-
Vanguard Group Inc Valley Forge, PA2.14MShares$3.46 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.56MShares$2.53 Million0.0% of portfolio
-
Advisor Group Holdings, Inc. Phoenix, AZ1.18MShares$1.91 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA871KShares$1.41 Million0.0% of portfolio
-
Wealthspire Advisors, LLC New York, NY398KShares$645,3650.0% of portfolio
About GALECTIN THERAPEUTICS INC
- Ticker GALT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,426,000
- Market Cap $96.3M
- Description
- Galectin Therapeutics Inc., a clinical stage biopharmaceutical company, engages in the research and development of therapies for fibrotic, cancer, and other diseases. The company's lead product candidate is belapectin (GR-MD-02) galectin-3 inhibitor, a galactoarabino-rhamnogalacturonan polysaccharide polymer that is in Phase III clinical trial f...